Delivery Order SPE2DE23D0008-SPE2D626F79T2
- Not listed
- On November 12, 2025, the Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,614.00 to Allergan USA Inc. for Natrelle Inspira SCF 325CC breast implants. The contract is a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The order is expected to be completed by November 18, 2025, with performance to be...
- The Defense Logistics Agency's Medical Supply Chain division awarded Allergan USA Inc. a $2,814.00 fixed-price delivery order for Natrelle Inspira SCF 365CC breast implants with an ultimate completion date of August 22, 2025. This delivery order, issued on July 30, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle contracts valued at $13.5 million for Natrelle breast implants and surgical devices established in December 2022. The contract does not...
- The U.S. Department of Defense Medical Supply Chain, operating through the Defense Logistics Agency Troop Support Medical, awarded a $2,814 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCX 800cc breast implants. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 25, 2025, represents a child order under one of Allergan's existing Indefinite Delivery Vehicles—specifically a $13.5 million IDV for...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,607.00 fixed-price delivery order to Allergan USA Inc. on September 15, 2025, for Natrelle Inspira SCM 520CC breast implants. The delivery order, which has no set-aside designation, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicles with DLA Troop Support Medical—specifically the $13.5 million IDV for Natrelle breast implants and surgical devices established on December 8, 2022. Allergan USA...
- On December 8, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a $3,807 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCF 385CC breast implants. This delivery order represents a child contract issued under Allergan's larger Indefinite Delivery Vehicle (IDV) agreement, a $13.5 million IDV for Natrelle breast implants and surgical devices established on December 8, 2022. The award was made without a set-aside...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,400.00 for Natrelle Inspira SCX 800cc breast implants by the Defense Logistics Agency's Medical Supply Chain division. The contract was awarded on November 25, 2025, with a completion date of November 28, 2025, and utilizes a fixed-price contract structure with economic price adjustment. The delivery order carries no set-aside designation and represents a child contract under one of Allergan's two...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,614.00 by the Defense Logistics Agency's Medical Supply Chain division on December 17, 2025, for Natrelle Inspira SCF 485CC breast implants. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of December 19, 2025, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on November 26, 2025, with completion scheduled for December 1, 2025. The contract covers the delivery of Natrelle Inspira SCM 485CC breast implants to support surgical procedures at military treatment facilities and related federal healthcare systems. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,228.00 fixed-price delivery order with economic price adjustment on December 9, 2025, for Natrelle Inspira SCF 385CC breast implants. The contract, which is expected to be completed by December 11, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order carries no set-aside designation and is funded through the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814.00 fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 18, 2025, for Natrelle Inspira SCX 750cc breast implants. The contract, which carries no set-aside designation, is classified as a child order under a larger Indefinite Delivery Vehicle and reflects Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The delivery order is set to...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F79T2Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a fixed-price delivery order valued at $3,300 to Allergan USA Inc. for Natrelle Inspira SCF 450cc breast implants on December 19, 2025, with an ultimate completion date of December 23, 2025. This delivery order is issued under one of Allergan's existing Indefinite Delivery/Indefinite Quantity contracts with DLA Troop Support Medical—specifically a $13.5 million IDV for Natrelle breast implants and surgical devices established on December 8, 2022. The contract incorporates fixed-price terms with economic price adjustment provisions and does not utilize any set-aside designations, reflecting Allergan's status as a sole-source provider of these specialized medical devices. Performance will occur at the company's facility in Irvine, California. Allergan USA Inc., a subsidiary of AbbVie Inc., is a leading supplier of breast implants and reconstructive surgical products to federal healthcare systems, including military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers. The underlying IDV structure enables efficient electronic ordering and fulfillment of Allergan's surgical products across Department of Defense research centers and hospitals, with on-site product support provided by Allergan representatives. This delivery order represents routine fulfillment under the established IDV vehicle designed to ensure timely availability of critical medical supplies for reconstructive and aesthetic surgical procedures throughout the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/18/25 |